128 related articles for article (PubMed ID: 9151165)
1. Detection of unknown primary head and neck tumors by positron emission tomography.
Braams JW; Pruim J; Kole AC; Nikkels PG; Vaalburg W; Vermey A; Roodenburg JL
Int J Oral Maxillofac Surg; 1997 Apr; 26(2):112-5. PubMed ID: 9151165
[TBL] [Abstract][Full Text] [Related]
2. [F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
Bohuslavizki KH; Klutmann S; Sonnemann U; Thoms J; Kröger S; Werner JA; Mester J; Clausen M
Laryngorhinootologie; 1999 Aug; 78(8):445-9. PubMed ID: 10488465
[TBL] [Abstract][Full Text] [Related]
3. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
Greven KM; Keyes JW; Williams DW; McGuirt WF; Joyce WT
Cancer; 1999 Jul; 86(1):114-8. PubMed ID: 10391570
[TBL] [Abstract][Full Text] [Related]
4. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Oral Oncol; 1999 Jul; 35(4):390-4. PubMed ID: 10645404
[TBL] [Abstract][Full Text] [Related]
5. Detection of unknown occult primary tumors using positron emission tomography.
Kole AC; Nieweg OE; Pruim J; Hoekstra HJ; Koops HS; Roodenburg JL; Vaalburg W; Vermey A
Cancer; 1998 Mar; 82(6):1160-6. PubMed ID: 9506364
[TBL] [Abstract][Full Text] [Related]
6. The role of positron emission tomography in occult primary head and neck cancers.
Safa AA; Tran LM; Rege S; Brown CV; Mandelkern MA; Wang MB; Sadeghi A; Juillard G
Cancer J Sci Am; 1999; 5(4):214-8. PubMed ID: 10439166
[TBL] [Abstract][Full Text] [Related]
7. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
[TBL] [Abstract][Full Text] [Related]
8. The impact of FDG PET on the management of occult primary head and neck tumours.
Wong WL; Saunders M
Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):461-6. PubMed ID: 14690001
[TBL] [Abstract][Full Text] [Related]
9. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
[TBL] [Abstract][Full Text] [Related]
10. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
[TBL] [Abstract][Full Text] [Related]
11.
Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S
Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271
[TBL] [Abstract][Full Text] [Related]
12. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
Périé S; Talbot JN; Monceaux G; Grahek D; Kerrou K; Montravers F; St Guily JL
Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):755-60. PubMed ID: 10961809
[TBL] [Abstract][Full Text] [Related]
13. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
Stoeckli SJ; Mosna-Firlejczyk K; Goerres GW
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):411-6. PubMed ID: 12634970
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Lassen U; Daugaard G; Eigtved A; Damgaard K; Friberg L
Eur J Cancer; 1999 Jul; 35(7):1076-82. PubMed ID: 10533451
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
[TBL] [Abstract][Full Text] [Related]
16. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
[TBL] [Abstract][Full Text] [Related]
17. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
Sheikholeslam-zadeh R; Choufani G; Goldman S; Hassid S
Acta Otorhinolaryngol Belg; 2002; 56(1):77-82. PubMed ID: 11894635
[TBL] [Abstract][Full Text] [Related]
18. FDG PET detection of unknown primary tumors.
Bohuslavizki KH; Klutmann S; Kröger S; Sonnemann U; Buchert R; Werner JA; Mester J; Clausen M
J Nucl Med; 2000 May; 41(5):816-22. PubMed ID: 10809197
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy.
Bailet JW; Abemayor E; Jabour BA; Hawkins RA; Ho C; Ward PH
Laryngoscope; 1992 Mar; 102(3):281-8. PubMed ID: 1545657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
